A multi-site validation in India of the line probe assay for the rapid diagnosis of multi-drug resistant tuberculosis directly from sputum specimens.
<h4>Unlabelled</h4>Rifampicin (R) and isoniazid (H) are key first-line anti-tuberculosis drugs. Failure to detect resistance to these two drugs early results in treatment failure and poor clinical outcomes. The study purpose was to validate the use of the GenoType MTBDRplus line probe as...
Saved in:
| Main Authors: | Neeraj Raizada, K S Sachdeva, D S Chauhan, Bharti Malhotra, Kishore Reddy, P V Dave, Yamuna Mundade, Pranav Patel, Ranjani Ramachandran, Ram Das, Rajesh Solanki, Douglas Fraser Wares, Suvanand Sahu, Rick O'Brien, C N Paramasivan, Puneet K Dewan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0088626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
by: Kuldeep Singh Sachdeva, et al.
Published: (2015-01-01) -
Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India.
by: Neeraj Raizada, et al.
Published: (2014-01-01) -
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
by: Kuldeep Singh Sachdeva, et al.
Published: (2015-01-01) -
Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India.
by: Neeraj Raizada, et al.
Published: (2015-01-01) -
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis.
by: Sreenivas Achuthan Nair, et al.
Published: (2016-01-01)